D6068
N-[4-[(6,7-Dimethoxy-4-quinazolinyl)amino]phenyl]benzamide 盐酸盐
≥98% (HPLC), solid
别名:
4-(4′-Benzamidoanilino)-6,7-dimethoxyquinazoline 盐酸盐, Aurora Kinase Inhibitor II
登录查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C23H20N4O3 · HCl
化学文摘社编号:
分子量:
436.89
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77
方案
≥98% (HPLC)
表单
solid
颜色
yellow
溶解性
H2O: <2 mg/mL
DMSO: ~2.4 mg/mL (with warming up to 60°C for 1 minute)
创始人
AstraZeneca
储存温度
2-8°C
SMILES字符串
Cl.COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC
InChI
1S/C23H20N4O3.ClH/c1-29-20-12-18-19(13-21(20)30-2)24-14-25-22(18)26-16-8-10-17(11-9-16)27-23(28)15-6-4-3-5-7-15;/h3-14H,1-2H3,(H,27,28)(H,24,25,26);1H
InChI key
OQCLKJREASBKNO-UHFFFAOYSA-N
生化/生理作用
Aurora Kinase Inhibitor
特点和优势
This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Nicola M Heron et al.
Bioorganic & medicinal chemistry letters, 16(5), 1320-1323 (2005-12-13)
A novel series of 5-aminopyrimidinyl quinazolines has been developed from anilino-quinazoline 1, which was identified in a high throughput screen for Aurora A. Introduction of the pyrimidine ring and optimisation of the substituents both on this ring and at the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持